1st Quarter - Report

THE NICKLES GROUP, LLC for UCB, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. H.R. 946, ORPHAN Cures Act. Issues related to access to home infusion. Issues related to pharmacy benefit management reforms.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 946 (119th)

Taxation/Internal Revenue Code TAX

H.R. 1990, the American Innovation and R&D Competitiveness Act, as it relates to the R&D tax credit. Monitored H.R. 591, Defending American Jobs & Investment Act and H.R. 2423, Unfair Tax Prevention Act, as they relate to taxation of foreign-based multinationals. Issues related to the 2025 extension of the Tax Cut and Jobs Act provisions impacting corporations and the Orphan Drug Tax Credit.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 591 (119th), H.R. 1990 (119th), H.R. 2423 (119th)

Health Issues HCR

Issues related to medication step therapy. S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.

LobbyistCovered position, as disclosed
BRETT BAKER —
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 864 (119th)

Trade (domestic/foreign) TRD

Issues related to tariffs.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.